DARA Biosciences (DARA)

0.7053 +0.01  +0.76%  May 21, 5:01PM
Add to Watchlists Create an Alert

DARA Biosciences R&D Expense Quarterly:

1.515M for Dec. 31, 2012
View Full Chart

DARA Biosciences R&D Expense Quarterly Chart

    DARA Biosciences Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1.515M
    Sept. 30, 2012 0.3578M
    June 30, 2012 0.5462M
    March 31, 2012 0.3158M
    Dec. 31, 2011 0.6804M
    Sept. 30, 2011 0.5622M
    June 30, 2011 0.9945M
    March 31, 2011 0.3964M
    Dec. 31, 2010 0.5282M
    Sept. 30, 2010 1.189M
    June 30, 2010 1.266M
    March 31, 2010 0.3596M
    Dec. 31, 2009 0.4378M
    Sept. 30, 2009 0.2959M
    June 30, 2009 0.2629M
    March 31, 2009 0.8906M
    Dec. 31, 2008 1.126M
    Sept. 30, 2008 2.705M
    June 30, 2008 2.030M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    DARA R&D Expense Quarterly Benchmarks

    Companies
    Cyclacel Pharmaceuticals 1.996M
    Prana Biotechnology
    Sangamo BioSciences 9.282M

    DARA R&D Expense Quarterly Rankings

    Overall 85th percentile
    1164 of 8002
    Sector 48th percentile
    351 of 684 in Healthcare
    Industry 35th percentile
    159 of 248 in Biotechnology

    DARA R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.2629M Jun 2009
    Maximum 2.705M Sep 2008
    Average 0.8663M